Literature DB >> 9692874

Enhanced Th2-like responses in IL-1 type 1 receptor-deficient mice.

A R Satoskar1, M Okano, S Connaughton, A Raisanen-Sokolwski, J R David, M Labow.   

Abstract

IL-1 has a number of effects on T cell growth but a specific role for IL-1 in T cell responses in vivo has not been elucidated. In this study the role of IL-1 in Th1/Th2 responses was examined in mice deficient for the IL-1 type 1 receptor (IL-1RI-/-) during cutaneous Leishmania major infection or following immunization with keyhole limpet hemocyanin (KLH). After inoculation of L. major stationary phase promastigotes into the hind footpad, both IL-1RI-/- and wild-type (WT) mice developed small lesions which resolved spontaneously. Lymph node cells from infected IL-1RI-/- mice produced significantly more IL-4 and IL-10 than those from WT mice following antigenic stimulation in vitro. Splenocytes from IL-1RI-/- and WT mice showed similar levels of antigen-induced proliferation. In contrast, splenocyte cultures from the IL-1RI-/- mice contained significantly more IL-4 than those from WT mice. Similar results were also obtained after immunization with KLH. While lymph node cells from both IL-1RI-/- and WT mice displayed similar levels of KLH-specific proliferation, those from IL-1RI-/- mice produced significantly more IL-4 than those from WT mice. Conversely, antigen-stimulated lymph node cells from WT mice secreted significantly greater amounts of IFN-gamma as compared with those from IL-1RI-/- mice. These data indicate that while IL-1 is not required for mounting an immune response or antigen-dependent proliferation, it appears to be required for normal regulation of Th1/Th2 responses and may function to negatively regulate IL-4 expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692874     DOI: 10.1002/(SICI)1521-4141(199807)28:07<2066::AID-IMMU2066>3.0.CO;2-X

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

Review 1.  Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?

Authors:  C Jorgensen; F Apparailly; J Sany
Journal:  Ann Rheum Dis       Date:  1999-03       Impact factor: 19.103

2.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

3.  Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.

Authors:  Afton L Thompson; Brandi T Johnson; Gregory D Sempowski; Michael D Gunn; Baidong Hou; Anthony L DeFranco; Herman F Staats
Journal:  J Immunol       Date:  2012-02-15       Impact factor: 5.422

4.  Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome.

Authors:  Xianbao He; Samrawit Mekasha; Nikolaos Mavrogiorgos; Katherine A Fitzgerald; Egil Lien; Robin R Ingalls
Journal:  J Immunol       Date:  2010-04-14       Impact factor: 5.422

5.  Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.

Authors:  Kristy J Szretter; Shivaprakash Gangappa; Xuihua Lu; Chalanda Smith; Wun-Ju Shieh; Sherif R Zaki; Suryaprakash Sambhara; Terrence M Tumpey; Jacqueline M Katz
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

6.  Do you see what I see: Recognition of protozoan parasites by Toll-like receptors.

Authors:  Debopam Ghosh; Jason S Stumhofer
Journal:  Curr Immunol Rev       Date:  2013-08

7.  Inflammasome-derived IL-1β production induces nitric oxide-mediated resistance to Leishmania.

Authors:  Djalma S Lima-Junior; Diego L Costa; Vanessa Carregaro; Larissa D Cunha; Alexandre L N Silva; Tiago W P Mineo; Fredy R S Gutierrez; Maria Bellio; Karina R Bortoluci; Richard A Flavell; Marcelo T Bozza; João S Silva; Dario S Zamboni
Journal:  Nat Med       Date:  2013-06-09       Impact factor: 53.440

8.  Recombinant Leishmania major secreting biologically active granulocyte-macrophage colony-stimulating factor survives poorly in macrophages in vitro and delays disease development in mice.

Authors:  Carole Dumas; Anthony Muyombwe; Gaétan Roy; Claudine Matte; Marc Ouellette; Martin Olivier; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

9.  A proposed role for Leishmania major carboxypeptidase in peptide catabolism.

Authors:  Clara E Isaza; Xuejun Zhong; Lucia E Rosas; James D White; Rita P-Y Chen; George F-C Liang; Sunney I Chan; Abhay R Satoskar; Michael K Chan
Journal:  Biochem Biophys Res Commun       Date:  2008-06-06       Impact factor: 3.575

10.  MyD88 negatively controls hypergammaglobulinemia with autoantibody production during bacterial infection.

Authors:  Anne Woods; Pauline Soulas-Sprauel; Benoit Jaulhac; Bérénice Arditi; Anne-Marie Knapp; Jean-Louis Pasquali; Anne-Sophie Korganow; Thierry Martin
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.